The Longitudinal Course of Psychopathology in Cushing’s Syndrome after Correction of Hypercortisolism
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Endogenous Cushing’s syndrome (CS) is associated with significant psychopathology during the course of the disease. The purpose of this study was to evaluate the psychological and endocrine status of patients with CS after correction of their hypercortisolism. Thirty-three patients with active CS were examined before and at 3 months (28 patients), 6 months (25 patients), and 12 months (29 patients) after correction of hypercortisolism. Before cure, 66.7% of the patients had significant psychopathology, with the predominant diagnosis of atypical depressive disorder (AD) in 51.5% and/or major affective disorder in 12%. After cure, overall psychopathology decreased significantly to 53.6% at 3 months, 36% at 6 months, and 24.1% at 12 months, when there was a parallel recovery of the hypothalamic-pituitary-adrenal axis assessed by serial morning ACTH stimulation tests. There was an inverse correlation between psychological recovery and baseline morning cortisol, but no correlation with ACTH-stimulated cortisol values at 60 min. AD continued to be the prevailing diagnosis after correction of hypercortisolism, whereas the frequency of suicidal ideation and panic increased. The presence of AD before and after correction of hypercortisolism might be due to glucocorticoid-induced suppression of hypothalamic CRH secretion. The slight increase in the incidence of panic after correction of hypercortisolism might be due to a decreased glucocorticoid restraint at the central arousal/sympathetic catecholaminergic system. We conclude that CS is associated with AD symptomatology, which gradually improves with time after correction of hypercortisolism. Health care providers should be aware of changes in symptomatology, including suicidal ideation and panic attacks, that occur in a subgroup of patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GWS occurs due to a relative decrease in cortisol concentrations after surgical cure, and consists not only of physical signs and symptoms, but also psychiatric symptoms (such as depression and anxiety), which affect recovery and overall quality of life24,25.”
From Extensive clinical experience: hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess (2018) · cites this paper as [24]
Citations
Cites
A Coefficient of Agreement for Nominal Scales
Cohen, J. (1960) · Educational and Psychological Measurement · doi:10.1177/001316446002000104 · Cited by 42,398 · cited 1×
“Interrater agreement on the presence or absence of a psychiatric diagnosis was made on approximately 32% of the posttreatment interviews throughout the course of the study. The average k coefficient ( 22 ) was 0.87.”
BackgroundInfluential(1970) · Cited by 24,983
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689 · cited 3×
“In an earlier report we showed that over 50% of patients with active CS present with symptoms of atypical depression (6), a phenomenon compatible with the fact that patients with active CS exhibit glucocorticoid-induced suppression of their CRH neurons ( 9 , 10, 17).”
BackgroundResultInfluentialSelf-citationWilamowska (2010) · doi:10.1001/archpsyc.1988.01800320058007 · Cited by 2,115 · cited 1×
“The Hamilton Rating Scale for Depression ( 24 ) consists of 21 items and yields scores of depression severity from 0‐65.”
MethodDEMITRACK, M. A., DALE, J. K., STRAUS, S. E., LAUE, L., LISTWAK, S. J., KRUESI, M. J. P., CHROUSOS, G. P., & GOLD, P. W. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1224 · Cited by 727 · cited 1×
“To date, the coexistence of atypical depression and low hypothalamic CRH secretion has been shown or inferred in patients with active CS (10), seasonal affective disorder (11), the chronic fatigue/fibromyalgia syndromes ( 12 , 13), and the postpartum blues/depression syndromes (14).”
BackgroundSelf-citationHypothalamic–pituitary–adrenal axis perturbations in patients with fibromyalgia
Crofford, L. J., Pillemer, S. R., Kalogeras, K. T., Cash, J. M., Michelson, D., Kling, M. A., Sternberg, E. M., Gold, P. W., Chrousos, G. P., & Wilder, R. L. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371105 · Cited by 508 · cited 1×
“To date, the coexistence of atypical depression and low hypothalamic CRH secretion has been shown or inferred in patients with active CS (10), seasonal affective disorder (11), the chronic fatigue/fibromyalgia syndromes (12, 13 ), and the postpartum blues/depression syndromes (14).”
BackgroundSelf-citationKendler, K. S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050025004 · Cited by 323
Risk factors and long-term outcome in pituitary-dependent Cushing's disease
Sonino, N. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.7.2647 · Cited by 265 · cited 1×
“Others reported that postoperative depression was a predictor of both nonremission and relapse after pituitary surgery of Cushing’s disease ( 33 ).”
BackgroundPhenelzine v Imipramine in Atypical Depression: A Preliminary Report
Liebowitz, M. R. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790180039005 · Cited by 261
(1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.1.52 · Cited by 247
Research works printed but not linked: 4
- Gifford, 1970, 49, 397
- Kelly, 1983, 142, 16
- Munabi, 1986, 63, 1036
- Endicott, 1979, 136, 52
Cited by
Items 201–264 of 264
Malik, O., & Westphal, B. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0037 · Cited by 2
The Cognitive, Psychological, and Emotional Presentation of Cushing’s Disease
Katznelson, L. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804340-0.00004-8 · Cited by 3
Management of glucocorticoids following adrenalectomy for ACTH ‐independent Cushing's syndrome
Seejore, K., & Murray, R. D. (2018) · Clinical Endocrinology · doi:10.1111/cen.13839 · Cited by 2
Park, Y., Gao, F. M., Sim, I., & Gilfillan, C. P. (2023) · JCEM Case Reports · doi:10.1210/jcemcr/luad075 · Cited by 2
“While psychiatric conditions such as depression and eating disorders can cause PCS, neuro-psychiatric and cognitive changes are also common symptoms of CS, reported in more than 50% of patients [5].”
BackgroundThe neurocognitive consequences of non-functioning pituitary adenoma and its treatment
Tooze, A. (2010) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 3
Inoue, S., Hayashi, T., Teishima, J., & Matsubara, A. (2020) · Urologia Internationalis · doi:10.1159/000508765 · Cited by 1
Surgical Approaches to Cushing's Disease
Smith, P. W., & Hanks, J. B. (2011) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2011.06.006 · Cited by 1
Glucocorticoid Regulation of Neurocognitive and Neuropsychiatric Function
Pereira, A. M., & Meijer, O. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_2 · Cited by 1
Psychiatric Disease in Hypothalamic–Pituitary Disorders
Sievers, C., & Stalla, G. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00014-3 · Cited by 1
Hominin Evolution II: Sapiens, Masters of the Known Universe
Tracy, D. K. (2021) · Cambridge University Press eBooks · doi:10.1017/9781911623625.006 · Cited by 1
Introduction to epigenetics in psychiatry
Lee, R. S., & Avramopoulos, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823577-5.00009-x · Cited by 2
Interface de doenças endocrinológicas com repercussões psiquiátricas: uma revisão de literatura
Lafayette, D. D. S. A., Urquiza, P. A. C., Brito, E. M. C., Costa, S. P. G. A., & Cantilino, A. (2021) · Debates em Psiquiatria · doi:10.25118/2763-9037.2021.v11.271 · Cited by 1
“O acompanhamento psicoterápico pode ser útil, principalmente na presença de transtornos afetivos [47, 48].”
BackgroundLate-onset, treatment-resistant anxiety and depression
Carr, A. (2021) · Current Psychiatry · doi:10.12788/cp.0160 · Cited by 1
Craighead, W. E., Klein, D. N., Gillespie, C. F., Ritschel, L. A., & Phillips, K. E. (2017) · Wiley eBooks · doi:10.1002/9781394258949.ch7 · Cited by 1
The Role of the Endocrinologist
Colao, A., & Lombardi, G. (2003) · Springer eBooks · doi:10.1007/978-3-7091-6084-8_4 · Cited by 1
Glucocorticoids - outcome in patients with glucocorticoid deficiency and Cushing's syndrome
Ragnarsson, Ó. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Long-Term Complications of Hypercortisolism
Pivonello, R., Iacuaniello, D., Simeoli, C., Martino, M. C. D., & Colao, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64305-2 · Cited by 2
Cushing Syndrome—Unilateral Adrenal Adenoma
Dalmazi, G. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65213-3 · Cited by 1
Diagnosis and Treatment of Pediatric Cushing’s Disease
Hughes, C. R., Storr, H. L., Grossman, A. B., & Savage, M. O. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_14 · Cited by 1
Psychosocial Aspects of Cushing’s Disease
Sonino, N. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_18
“Depression may improve in Cushing’s syndrome upon achievement of normal cortisol levels [22, 23, 31, 47, 48, 51–54].”
InfluentialAulinas, A. (2015) · TDX (Tesis Doctorals en Xarxa)
Signs and Symptoms of Pituitary Disease
Fernández-Rodríguez, E., Bernabéu, I., Casanueva, F. F., Kassi, E. N., Kaltsas, G., Chrousos, G. P., & Golden, V. (2013) · Wiley eBooks · doi:10.1002/9781118559406.ch2
Self-citationCushing's Syndrome : hormonal secretion patterns, treatment and outcome
van Aken, & Otto, M. (2005)
General Psychological and Psychosocial Effects of Pituitary Disorders
Golden, V. (2013) · Wiley eBooks · doi:10.1002/9781118559406.ch28
Mujer con trastorno de la personalidad y múltiples factores de riesgo cardiovascular
González, P. C., & Teira, B. G. (2006) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(06)71355-x
Nam, K.-J., Kim, Y. J., Lee, S. Y., Lee, J. G., Cho, Y. H., Lee, Y.-H., Choi, E., Tak, Y. J., Yi, D., Park, S., et al. (2013) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2013.34.4.289 · Cited by 1
Neurologische und psychiatrische Symptome bei Patienten mit Hypophysenadenomen
Sievers, C. (2012) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Aus der Universitätsklinik für Neurochirurgie Tübingen
Direktor, Ä., & Tatagiba, M. S. (2012)
Clinical Features of Cushing’s Syndrome
Bruno, O. D. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-449-4_5 · Cited by 28
MÁSTER EN INVESTIGACIÓN BIOMÉDICA TRASLACIONAL
Castano, J. P., Luque, R. M., & Gahete, M. D. (2013)
Langenecker, S. A., Gomez‐Hassan, D. M., Davison, J. L., Hook, J. N., Giordani, B., SCHTEINGART, D. E., & Starkman, M. N. (2015) · Journal of Systems and Integrative Neuroscience · doi:10.15761/jsin.1000110
“Studies with this population have formed one of the most provocative links in the chain towards understanding reversibility of both hippocampal atrophy and cognitive decrements in human studies [3,21-26].”
BackgroundStratakis, C. A. (2015) · The Endocrine Society eBooks · doi:10.1210/mtp4.9781936704941.ch50
Crespo, I., & Webb, S. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00083-3
Epidemiology and Etiology of Cushing’s Disease
Tritos, N. A., & Biller, B. M. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804340-0.00002-4
Writers, A. M. (2017) · Drugs & Therapy Perspectives · doi:10.1007/s40267-017-0444-4 · Cited by 2
Wilkinson, I. C. E., Savage, M. O., & Storr, H. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65338-2
Effects of Glucocorticoids on the Brain
Pereira, A. M., Webb, S. M., & Meijer, O. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64329-5
A case of challenging post-operative management in adrenal Cushing's syndrome
Vanderpant, N., Sharma, A., & Bravis, V. (2018) · Endocrine Abstracts · doi:10.1530/endoabs.59.ep19
Bourdeau, I., & Forget, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-56782-2_548-3
Bengtsson, D. (2021) · Linköping University medical dissertations · doi:10.3384/diss.diva-174806 · Cited by 1
Behavioral medical epigenetics
Cox, O., & Lee, R. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823928-5.00017-7
Corticotropin-Dependent Cushing Syndrome Can Be Frequently Misdiagnosed
Young, W. F., & Bancos, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-79285-1.00054-6
Young, W. F., & Bancos, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-79285-1.00016-9
Hypercortisolism and Behavioral Neuroscience
Vives, A. S., Webb, S. M., & Resmini, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819641-0.00093-1
Bourdeau, I., & Forget, H. (2018) · Springer eBooks · doi:10.1007/978-3-319-57111-9_548
Heuser, I. (1999) · Springer eBooks · doi:10.1007/978-3-642-60174-3_8
Bourdeau, I., & Forget, H. (2010) · Springer eBooks · doi:10.1007/978-0-387-79948-3_548
Prolonged Adrenal Insufficiency after Unilateral Adrenalectomy for Cortisolic Adenoma
Akioud, F., Ajdi, F., & Damoune, I. (2023) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2023.133005
Gillespie, C. F., & Nemeroff, C. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00046-7
Savage, M. O., & Storr, H. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00093-5
Long-term complications of hypercortisolism
Pivonello, R., Crescenzo, E. M., Simeoli, C., Paola, N. D., Larocca, A., & Colao, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00123-0
Psycho-Neurological and Immunological Aspects of Cushing’s Syndrome
Matos, T., Sapinho, I., Sagarribay, A., & Marques, P. (2024) · Integrated science · doi:10.1007/978-3-031-72079-6_28
Cushing syndrome—Unilateral adrenal adenoma
Dalmazi, G. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00221-1
Psychose nach Bronchoskopie mit metabolischer Alkalose
Schroll, S., Dietmaier, L., Girlich, C., & Pfeifer, M. (2025) · Die Innere Medizin · doi:10.1007/s00108-025-01881-w
Síndrome de cushing : aspectos psicológicos relacionados ao excesso de cortisol
Lhul, R. V. D. S. (2025) · Lume (Universidade Federal do Rio Grande do Sul) · Cited by 1
The role of chromatin remodelers in dopaminoceptive neurons
Zayed, A. (2019) · theses.fr (ABES) · doi:10.70675/f1d09c9dz29c5z44e4zae26z358715db672e
Rang social, système dopaminergique et réponse au stress
Battivelli, D. (2019) · theses.fr (ABES) · doi:10.70675/b11d29f4z1bf3z4003z81f9z8c69988b277b
Potential mechanisms of the glucocorticoid withdrawal syndrome
Snyder, C. N., Frontera, E. D., Meng, J., Wallace, B. I., & Spencer-Segal, J. L. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag062
Kaminer, K., Shimon, I., Rudman, Y., Diker‐Cohen, T., Kushnir, S., Shochat, T., Sufaro, Y. Z., Tal, N., Serebro, M., Fleseriu, M., et al. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag125
Erbe, S. (2009) · Qucosa (Saxon State and University Library Dresden)
Nebennierenrinde und Glucocorticoide
Allolio, B., Arlt, W., Bornstein, S., & Reincke, M. (2001) · Springer eBooks · doi:10.1007/978-3-642-56784-1_3
Metadata
- Authors
- Dorn, L. D., Burgess, E. S., Friedman, T. C., Dubbert, B., Gold, P. W., & Chrousos, G. P.
- Affiliations
- University of Pittsburgh (US)
- Brown University (US)
- Cedars-Sinai Medical Center (US)
- the Departments of Behavioral Pediatrics (B.D.), Bethesda, Maryland 20892;
- National Institute of Mental Health (US)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
- Corresponding author
- Dorn, Lorah D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1997-03-01
- Volume
- 82
- Issue
- 3
- Pages
- 912-919
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2022989916
- Cited by
- 260
- References
- 31
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 10 · 2023: 10 · 2022: 8 · 2021: 16 · 2020: 11 · 2019: 8 · 2018: 15 · 2017: 11 · 2016: 10 · 2015: 16 · 2014: 12 · 2013: 20 · 2012: 14
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- Cushing's syndrome, hypercortisolism, psychopathology, major affective disorders, hypothalamic-pituitary-adrenal axis, ACTH stimulation test, morning cortisol, suicidal ideation, panic attacks, longitudinal course
- MeSH terms
- Adrenalectomy, Adult, Mental Disorders, Cushing Syndrome, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Longitudinal Studies, Male, Medical Records, Middle Aged, Pituitary-Adrenal System, Postoperative Complications, Prospective Studies, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.